An Innovative Influenza Vaccination Policy: Targeting Last Season's Patients

DSpace/Manakin Repository

An Innovative Influenza Vaccination Policy: Targeting Last Season's Patients

Citable link to this page

 

 
Title: An Innovative Influenza Vaccination Policy: Targeting Last Season's Patients
Author: Yamin, Dan; Gavious, Arieh; Solnik, Eyal; Davidovitch, Nadav; Balicer, Ran D.; Galvani, Alison P.; Pliskin, Joseph S.

Note: Order does not necessarily reflect citation order of authors.

Citation: Yamin, Dan, Arieh Gavious, Eyal Solnik, Nadav Davidovitch, Ran D. Balicer, Alison P. Galvani, and Joseph S. Pliskin. 2014. “An Innovative Influenza Vaccination Policy: Targeting Last Season's Patients.” PLoS Computational Biology 10 (5): e1003643. doi:10.1371/journal.pcbi.1003643. http://dx.doi.org/10.1371/journal.pcbi.1003643.
Full Text & Related Files:
Abstract: Influenza vaccination is the primary approach to prevent influenza annually. WHO/CDC recommendations prioritize vaccinations mainly on the basis of age and co-morbidities, but have never considered influenza infection history of individuals for vaccination targeting. We evaluated such influenza vaccination policies through small-world contact networks simulations. Further, to verify our findings we analyzed, independently, large-scale empirical data of influenza diagnosis from the two largest Health Maintenance Organizations in Israel, together covering more than 74% of the Israeli population. These longitudinal individual-level data include about nine million cases of influenza diagnosed over a decade. Through contact network epidemiology simulations, we found that individuals previously infected with influenza have a disproportionate probability of being highly connected within networks and transmitting to others. Therefore, we showed that prioritizing those previously infected for vaccination would be more effective than a random vaccination policy in reducing infection. The effectiveness of such a policy is robust over a range of epidemiological assumptions, including cross-reactivity between influenza strains conferring partial protection as high as 55%. Empirically, our analysis of the medical records confirms that in every age group, case definition for influenza, clinical diagnosis, and year tested, patients infected in the year prior had a substantially higher risk of becoming infected in the subsequent year. Accordingly, considering individual infection history in targeting and promoting influenza vaccination is predicted to be a highly effective supplement to the current policy. Our approach can also be generalized for other infectious disease, computer viruses, or ecological networks.
Published Version: doi:10.1371/journal.pcbi.1003643
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031061/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406883
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters